Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1.

bioRxiv : the preprint server for biology·2026
Same author

Functional propriospinal myoclonus in Alzheimer's disease: coincidence or a new challenge?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2025
Same author

Genetic Variants in the Transcription Factor Network: The Impact of <i>FOXC1, NOTCH1, RORC, FOXC</i>2 and <i>SOX18</i> in Primary Lymphedema.

Lymphology·2025
Same author

Self-monitoring of state dissociation and inner tension in psychotherapy for borderline personality disorder.

Journal of affective disorders·2025
Same author

Genetic Variants in <i>LZTR1, MAP2K1</i> and <i>RAF1</i>: Insights into the Role of RAS-MAPK Pathway in Primary Lymphedema.

Lymphology·2025
Same author

Genetic Study of HGF-MET Signaling Pathway in Primary Lymphedema Patients: Supporting Evidence for Loss of Function Variants in HGF.

Lymphology·2025
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Unrecognised ventricular dysfunction in COPD.

A Macchia1, J J Rodriguez Moncalvo, M Kleinert

  • 1Epidemiology Section, Dept of Internal Medicine, CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Buenos Aires, Argentina. macchia@negrisud.it

The European Respiratory Journal
|June 25, 2011
PubMed
Summary
This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) often coexist. Ventricular dysfunction in COPD patients significantly increases mortality risk, suggesting routine cardiac screening for these individuals.

More Related Videos

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

Related Experiment Videos

Last Updated: May 31, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

Area of Science:

  • Cardiology
  • Pulmonology
  • Internal Medicine

Background:

  • Chronic congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are prevalent conditions with shared risk factors, yet often studied in isolation.
  • The coexistence of these diseases can complicate patient management and prognosis.
  • Understanding the interplay between cardiac and pulmonary dysfunction is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the prevalence of left ventricular dysfunction in patients with COPD.
  • To assess the prevalence of airway obstruction in patients with CHF.
  • To evaluate the prognostic impact of these coexisting conditions on patient survival.

Main Methods:

  • A prospective cohort study involving 201 stable CHF patients (≥60 years) and 218 stable COPD patients (≥60 years).
  • CHF patients underwent spirometry; COPD patients underwent echocardiography and B-type natriuretic peptide (BNP) measurement.
  • Patients were followed for 2 years to assess mortality and survival rates.

Main Results:

  • Airway obstruction was present in 37.3% of CHF patients.
  • Ventricular dysfunction was identified in 17% of COPD patients.
  • Ventricular dysfunction in COPD patients was associated with a trend towards increased mortality (HR 2.34, p=0.053), while airway obstruction in CHF patients did not affect survival.

Conclusions:

  • CHF and COPD frequently coexist in older adults.
  • Ventricular dysfunction is a significant predictor of worsened survival in COPD patients.
  • Routine cardiac assessment (BNP or echocardiogram) is recommended for COPD patients due to the high prevalence and prognostic implications of ventricular dysfunction.